Dimethylformamide → HCID 21187559, compound
Reaction equation
[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[CH:16]=[CH:15][CH:14]=[C:13]3[C:9]=2[CH:10]=[C:11]([CH3:17])[NH:12]3)[CH2:4][CH2:3]1.O(Cl)Cl.[OH-].[Na+].CN(C)[CH:25]=[O:26]>>[CH:25]([C:10]1[C:9]2[C:13](=[CH:14][CH:15]=[CH:16][C:8]=2[N:5]2[CH2:4][CH2:3][N:2]([CH3:1])[CH2:7][CH2:6]2)[NH:12][C:11]=1[CH3:17])=[O:26]Participants
Procedure
To a stirred solution of 4-methyl-1-(2-methyl-1H-indol-4-yl)piperazine (0.247 g, 1.08 mmol) in anhydrous N,N-dimethylformamide (1 mL) at 0° C. was added dropwise a solution of phorsphorus oxychloride (0.16 g, 1.04 mmol) in anhydrous N,N-dimethylformamide (1 mL). The resulting reaction solution was stirred at room temperature under nitrogen for 2 hours. An aqueous solution of sodium hydroxide (10% by weight, 3 mL) was then added, and the resulting solution was stirred at room temperature under nitrogen overnight. The reaction solution was then evaporated under reduced pressure, and the residue was chromatographed using silica gel (approximately 50 g) and elution with methylene chloride/methanol/ammonium hydroxide [10:1:0.1] to afford the title compound (0.060 g, 0.23 mmol, 22%) as an off-white foam: 1H NMR (DMSO-d6) δ12.14 (br s, NH), 10.46 (s, 1H), 7.14-7.08 (m, 2H), 6.88 (dd, J=1.4 and 7.1 Hz, 1H), 3.11 (br m, 8H), 2.66 (s, 3H); FAB LRMS (m/z, relative intensity) 259 (16), 258 (MH+, 100).
Workup
- customThe resulting reaction solution
- stirringthe resulting solution was stirred at room temperature under nitrogen overnight
- customThe reaction solution was then evaporated under reduced pressure
- customthe residue was chromatographed
- washsilica gel (approximately 50 g) and elution with methylene chloride/methanol/ammonium hydroxide [10:1:0.1]
Sources & evidence
- ORD record
- ord-0b26594386be426289cb52ace7defa8c
- Source dataset
- uspto-grants-2001_07
- Patent number
- US06255306B1
Reaction notes
Loading…